Fig. 2. Effects of hypoxia with simultaneous application of the KATP
channel antagonist BDM (60 µmol l-1) on cardiac muscle action
potential duration (APD). No significant change in APD50 or
APD90 was recorded when BDM was present during hypoxia
(N=6). Values are means ± 1 S.E.M.